Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accendra HealthACH +0.60%60 3-1 Month Momentum % is -7.82% as of Jul. 31, 2026. GuruFocus rates ACH with a GF Score™ of 60/100 and a GF Value™ of $5.44 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 120 Medical Distribution companies, Accendra Health ranks better than 51.67% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-31), Accendra Health's 3-1 Month Momentum % is -7.82%.
The industry rank for Accendra Health's 3-1 Month Momentum % or its related term are showing as below:
ACH's 3-1 Month Momentum % is ranked better than 51.67% of 120
companies
in the Medical Distribution industry
Industry Median: -8.145
vs ACH: -7.82
Accendra Health (NYSE:ACH) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Accendra Health 3-1 Month Momentum % Related Terms
ACH vs FOCL, YI, COSM: 3-1 Month Momentum % Comparison
For the Medical Distribution subindustry, Accendra Health's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health 3-1 Month Momentum % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Accendra Health's 3-1 Month Momentum % falls into.
Accendra Health (NYSE:ACH) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accendra Health (ACH) has a 3-1 Month Momentum % of -7.82% as of Jul. 31, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Accendra Health and its competitors. According to the industry distribution chart, Accendra Health ranks #58 out of 120 companies in the Medical Distribution industry, placing it in the top 48.3%.
Is Accendra Health's 3-1 Month Momentum % too high?
Accendra Health's current 3-1 Month Momentum % is -7.82%. Based on the distribution chart, Accendra Health ranks #58 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Accendra Health has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's 3-1 Month Momentum % compare to FOCL and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #58 out of 120 companies for 3-1 Month Momentum %. This puts Accendra Health in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Distribution company?
A good 3-1 Month Momentum % depends on the Medical Distribution industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Accendra Health and its competitors. Accendra Health's current 3-1 Month Momentum % is -7.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.44, compared to a current price of $3.34 — trading 38.6% below its estimated fair value. The current 3-1 Month Momentum % is -7.82%. Accendra Health's overall GF Score™ is 60/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Accendra Health (ACH), the current 3-1 Month Momentum % is -7.82% as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $3.34 is trading 38.6% below its estimated GF Value™ of $5.44.
GuruFocus considers Accendra Health to be Possible Value Trap.
Key valuation signals for ACH:
3-1 Month Momentum %: -7.82%
GF Value™: $5.44 vs. price of $3.34 (38.6% below fair value)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
60GF Score
Get the complete analysis for ACH
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 
